FDA Update on Avoiding Gadolinium Used in MRI

Home

Related Videos:

Diabetes and Kidney Disease
Robert C Stanton

Laparoscopic Nephrectomy
Rizk El Galley

Kidney Transplant
Michael Rees

Dialysis
Steve Ash

How Does Donating a Kidney Impact Donor's Heart
Todd Pesavento

What is Dialysis and Who Needs It?
Robert Goldstein

From: Rodrigo Duarte, rn

Category: FDA Warnings

Added: Oct 01, 2008

Description:

Gadolinium, which is commonly used during an MRI as a contrast agent, have a new FDA warning that they can cause NSF/NFD, nephrogenic systemic Fibrosis/Nephrogenic Fibrosing Dermopathy. These are diseases which cause fibrosis of the skin and internal organs. These problems can occur from a few days to a year after receiving the contrast agent. This videos tell you who is at risk and what the signs are.

Post a text comment

Nadia (Oct 11, 2008)

I am so upset to be reading this. I have an MRI every year. If they see something on my MRI, I have to have a needle guided biopsy. This has happened too many times in the past few years since I have been diagnosed with LCIS. My doctor who is at Sloan Kettering in New York City seems very competent. Now, I do not know if I want to go back. She says I will never die from breast cancer if I get this test. Should I be worried instead about Nephrogenic Fibrosing Dermopathy? This really scares me.

overthehill (Oct 02, 2008)

I can't have an MRI anyway because I have a pacemaker, but this scares the crap out of me. We are getting all these tests, and we don't know what it is doing to our bodies.

Join VideoMD for a free account, or Login if you are already a member.

VideoMD does not provide medical advice, diagnosis or treatment.